Skip to main content
Erschienen in:

15.01.2024 | Head and Neck

CT-guided core needle biopsies of head and neck tumors: a comprehensive monocenter analysis of safety and outcomes

verfasst von: Thomas Joseph Vogl, Heinrich Johannes Ketelsen, Scherwin Mahmoudi, Jan-Erik Scholtz, Vitali Koch, Leon David Grünewald, Peter Wild, Timo Stoever, Simon Bernatz

Erschienen in: European Radiology | Ausgabe 8/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Although core needle biopsy is an important tool in minimally invasive tissue sampling and diagnostics for head and neck masses, comprehensive data about safety and outcomes is lacking.

Purpose

To retrospectively evaluate the diagnostic performance and safety of computed tomography (CT)-guided percutaneous core needle biopsy of head and neck masses.

Material and methods

This retrospective single-center study included patients from 04/2007 to 12/2021, and a total of 156 core needle biopsies were evaluated. The initial histopathological results were compared with the long-term final diagnosis to evaluate the diagnostic yield of CT-guided core needle biopsies. The patients’ age, sex, and history of malignancy, as well as procedural complications and radiation exposure were collected.

Results

A total of 156 biopsies of 150 patients (mean age 56 years ± 17; 89 men) were evaluated. 57.3% (86/150) of patients had a history of malignancy. 55.1% (86/156) of the lesions were accessed by an infrahyoid needle approach. 92.9% (145/156) of biopsies yielded conclusive results. There were no false positives and 4 false negatives, resulting in a total false negative rate of 2.7% (4/145) and a total diagnostic yield of 90.4% (141/156). There were nine puncture-related complications (9/156–5.7%). None of the complications required further reintervention. The average dose length product was 311.3 mGy × cm.

Conclusion

CT-guided core needle biopsies of head and neck masses showed excellent results with high diagnostic yield and clinical safety.

Clinical relevance statement

General anesthesia for open biopsy carries a higher risk for elderly patients, and fine needle aspiration has a poor reputation in terms of its diagnostic yield. This study focuses on safety and diagnostic yield of CT-guided core needle biopsies.

Key Points

CT-guided core needle biopsy in head and neck tumors was a reliable and safe procedure.
The most common cause for an inconclusive biopsy result was a shortage of tissue collected during the biopsy.
During our study period of nearly 15 years, the radiation exposure of head and neck biopsies decreased.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Dittberner A, Friedl B, Wittig A et al (2020) Gender disparities in epidemiology, treatment, and outcome for head and neck cancer in Germany: a population-based long-term analysis from 1996 to 2016 of the Thuringian Cancer Registry. Cancers 12. https://doi.org/10.3390/cancers12113418 Dittberner A, Friedl B, Wittig A et al (2020) Gender disparities in epidemiology, treatment, and outcome for head and neck cancer in Germany: a population-based long-term analysis from 1996 to 2016 of the Thuringian Cancer Registry. Cancers 12. https://​doi.​org/​10.​3390/​cancers12113418
10.
Zurück zum Zitat Wagner JM, Monfore N, McCullough AJ et al (2019) Ultrasound-guided fine-needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses: comparison of diagnostic performance in treated squamous cell cancer versus all other lesions. J Ultrasound Med 38:2275–2284. https://doi.org/10.1002/jum.14918CrossRefPubMed Wagner JM, Monfore N, McCullough AJ et al (2019) Ultrasound-guided fine-needle aspiration with optional core needle biopsy of head and neck lymph nodes and masses: comparison of diagnostic performance in treated squamous cell cancer versus all other lesions. J Ultrasound Med 38:2275–2284. https://​doi.​org/​10.​1002/​jum.​14918CrossRefPubMed
Metadaten
Titel
CT-guided core needle biopsies of head and neck tumors: a comprehensive monocenter analysis of safety and outcomes
verfasst von
Thomas Joseph Vogl
Heinrich Johannes Ketelsen
Scherwin Mahmoudi
Jan-Erik Scholtz
Vitali Koch
Leon David Grünewald
Peter Wild
Timo Stoever
Simon Bernatz
Publikationsdatum
15.01.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2024
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10541-2

Neu im Fachgebiet Radiologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.